Clinical Trials Sponsored by Walter Hanel

Total 1549 results

Baxter Healthcare Corporation
PPD; Halozyme Therapeutics

Completed

Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children (INFUSE-PR)

Dehydration
Losordo, Douglas, M.D.
Baxter Healthcare Corporation

Completed

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia (ACT34-CLI)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
Nguyen, Davis B., M.D.
Baxter BioScience

Unknown

Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant

United States
Massachusetts General Hospital
Baxter Healthcare Corporation

Completed

EASI Access II --- Follow-up Study to the EASI Access Trial

Disaster Medicine | Dehydration | Difficult Intravenous Access

United States
Elisabethinen Hospital
Baxter Healthcare Corporation; ASOKLIF

Unknown

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine (immunisation)

Tick Borne Encephalitis

Austria, Czech Republic
Massachusetts General Hospital
Baxter Healthcare Corporation

Completed

Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial

Dehydration | Mass Casualty Incident

United States
Sunnybrook Health Sciences Centre
United States Department of Defense; Walter Reed National Military Medical...

Withdrawn

Placebo Versus Oxandrolone Supplementation in Trauma

Trauma Injury
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.

Plasmodium Falciparum

Kenya
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

Dengue

United States
Walter and Eliza Hall Institute of Medical Research
Melbourne Health; Royal Marsden NHS Foundation Trust

Completed

Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours (G3 RPLN PBC)

Testicular Neoplasms

Australia
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults

Dengue

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (DPIV-001)

Dengue Fever

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Withdrawn

TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant

Dengue

United States
Walter Reed National Military Medical Center
International Urogynecological Association (Grant); Section on Women's Health...

Unknown

Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments

Overactive Bladder | Urge Urinary Incontinence

United States
Walter Reed Army Medical Center
Eastern Virginia Medical School; University of Virginia; James Madison University

Completed

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

Tear Protein Lacritin in Human Tears

United States
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Completed

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Hoosier Cancer Research Network
Eli Lilly and Company; Walther Cancer Institute

Terminated

Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Lymphoma, B-Cell

United States
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Terminated

Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck

Head and Neck Cancer

United States
Alison Walker
Seagen Inc.

Terminated

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia

United States
Indiana University School of Medicine
Walther Cancer Institute

Completed

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

Cancer and Tobacco Abuse

United States
Womack Army Medical Center
United States Department of Defense; Walter Reed National Military Medical...

Recruiting

Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement (PREPARE)

Musculoskeletal Injuries

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (DPIV-002)

Dengue Fever

Puerto Rico
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center; Ohio State University

Unknown

Questionnaire Study for Gynecological Cancer Survivors

Uterine Cervical Neoplasms | Genital Neoplasms, Female | Ovarian Neoplasms | Endometrial Neoplasms | Vulvar Neoplasms | Vaginal Neoplasms

United States
Active Genomes Expressed Diagnostics, Corp
Walter Reed National Military Medical Center; Arizona Clinical Trials

Not yet recruiting

AGED Diagnostics Liver Disease Assessment (AGEDDX)

Healthy | NAFLD | NASH With Fibrosis

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Recruiting

A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults

Vaccine Reaction

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Recruiting

Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep

Sleep Deprivation | Mental Competency

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Enrolling by invitation

Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment (TES)

Sleep | Performance Enhancing Product Use
GlaxoSmithKline
Walter Reed Army Institute of Research (WRAIR); The PATH Malaria Vaccine Initiative...

Completed

Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults

Malaria

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds

Malaria

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Meningitis, Meningococcal, Serogroup B

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea (CJCV1-01)

Campylobacter Infection

United States
Fort Belvoir Community Hospital
Walter Reed National Military Medical Center; TriService Nursing Research Program

Completed

The Sound Mind Warrior Study

Stress | Anxiety

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Terminated

WR 279,396 Open Label Treatment Protocol in Tunisia

Cutaneous Leishmaniasis

Tunisia
Beth Israel Deaconess Medical Center
Walter Reed Army Medical Center

Completed

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Prostate Cancer

United States
Baxalta now part of Shire
Baxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)

Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Alpha 1-Antitrypsin Deficiency

Australia, New Zealand
Nasser Hanna, M.D.
Sanofi; Walther Cancer Institute

Completed

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Terminated

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Hoosier Cancer Research Network
Eli Lilly and Company; Walther Cancer Institute

Terminated

Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY SZ)

Schizophrenia and Related Disorders | Early Treatment-Resistance

Austria, Germany, Italy, Spain, United Kingdom
National Taiwan University Hospital
Baxter Healthcare Corporation

Recruiting

Blood Purification in Patients With Septic Shock

Severe Septic Shock

Taiwan
Lawson Health Research Institute
Baxter Healthcare Corporation

Completed

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

End Stage Renal Disease

Canada
Hospices Civils de Lyon
Baxter Healthcare Corporation

Completed

Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™ (ECRO)

Septic Shock | Peritonitis

France
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

End Stage Renal Disease

United States
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics (Hylenex)

Dehydration | Pediatrics | Cardiac Output

United States
Nobuyuki Katori
Baxter Healthcare Corporation

Unknown

Desflurane-induced Myocardial Protection

Aortic Valve Stenosis

Japan
National Taiwan University Hospital
Baxter Healthcare Corporation

Completed

Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients

Kidney Failure,Chronic

Taiwan
University of Maryland, Baltimore
Baxter International Inc.

Not yet recruiting

Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE (Ostene VIBe)

Postoperative Complications | Postoperative Hemorrhage | Intraoperative Complications | Blood Transfusion | Hemostasis | Spine Fusion | Intraoperative Bleeding | Intraoperative Blood Loss | Thoracolumbar Spine

United States
Dim3
Baxter Healthcare Corporation; University Hospital, Lille

Recruiting

Interpretation and Optimization of Nutrition in the Intensive Care Units (IONIC)

Nutritional Support

France
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY BD)

Bipolar Depression

Austria, Germany, Italy, Spain, United Kingdom
Centre Hospitalier Universitaire, Amiens
Baxter Healthcare Corporation

Recruiting

Effect of Oxiris® Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: a Pilot Prospective Monocentric Study (Oxicard Study). (OXICARD)

Surgery | Cardiac Event

France

Clinical Trials Sponsored by Walter Hanel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations